Senior Management Team
- Carole S. Ben-Maimon, M.D.
President & CEO - Paul J. Evans
VP Strategic Partnering & Business Development - Debra P. Gayda, Ph.D.
VP Quality and Regulatory Affairs - Heather C. Getz, CPA
VP Finance - Wayne S. Mulcahy, Ph.D.
VP Research & Development
Debra P. Gayda
Vice President Quality and Regulatory Affairs
Debra Gayda, Ph.D., is responsible for overseeing regulatory strategy and compliance for Alita's product portfolio. Dr. Gayda specializes in preclinical development and formulating regulatory strategies from the discovery stage of development to the worldwide registration of products in several therapeutic areas.
Dr. Gayda brings over 20 years of experience in both multi-national pharmaceutical and U.S. based biotechnology companies. She has been responsible for the submission of numerous INDs and the regulatory development program for projects within several therapeutic areas.
Dr. Gayda's previous leadership positions have included Vice President of Regulatory Affairs for ViroPharma and Vice President of Regulatory Development for Sanofi-Aventis. She also held regulatory positions at Apollon, Inc. and DuPont Merck Pharmaceutical Company as well as served as a post-doctoral scientist at Merck Sharp & Dohme Research Laboratories.
In her roles at ViroPharma and Sanofi-Aventis, Dr. Gayda was responsible for providing strategy and direction on regulatory activities for marketed products and products under investigation, preparing submissions/presentations for external parties including the FDA, international health authorities, and corporate partners, and ensuring compliance with DDMAC for promotional and medical affairs activities.
Dr. Gayda holds a Ph.D. from The University of Wisconsin in Madison where she was a recipient of The Monsanto Fund Fellowship for her research in toxicology. Additionally, Dr. Gayda is an honors graduate of Purdue University with a degree in biological science.
